Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With Schizophrenia
Public ClinicalTrials.gov record NCT01909466. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label, Multiple Dose, Safety and Tolerability Study of Aripiprazole IM Depot Administered in the Deltoid Muscle in Adult Subjects With Schizophrenia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To determine the safety and tolerability of multiple-dose administrations of aripiprazole intramuscular (IM) depot in the deltoid muscle in adult subjects with schizophrenia
Study identification
- NCT ID
- NCT01909466
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 141 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 64 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2013 (Type not available)
- Primary completion
- Mar 2014 (Actual)
- Completion
- Apr 2014 (Actual)
- Last update posted
- Jul 1, 2015
2013 – 2014
United States locations
- U.S. sites
- 11
- U.S. states
- 8
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Comprehensive Clinical Development | Cerritos | California | 90703 | — |
| Collaborative Neuroscience Network, Inc. | Garden Grove | California | 92845 | — |
| CNRI-San Diego | San Diego | California | 92101 | — |
| Comprehensive Clinical Development | Washington D.C. | District of Columbia | 20016 | — |
| Scientific Clinical Research, Inc. | Fort Lauderdale | Florida | 33308 | — |
| Compass Research North, LLC | Leesburg | Florida | 34748 | — |
| Atlanta Center for Medical Research | Atlanta | Georgia | 30308 | — |
| St. Louis Clinical Trials | St Louis | Missouri | 63118 | — |
| CRI Lifetree | Marlton | New Jersey | 08053 | — |
| CRI Lifetree | Philadelphia | Pennsylvania | 19139 | — |
| Community Clinical Research, Inc. | Austin | Texas | 78754 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01909466, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 1, 2015 · Synced Nov 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01909466 live on ClinicalTrials.gov.